FDA Inspection 783814 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3003103935

The FDA completed an inspection of Biomat USA, Inc. on May 12, 2012 in Danville, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 12, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Danville, VA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.